MedTrace Logo

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

NCT02029989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2024-04-04

Study results available
· View outcomes & findings →

Summary

The study was a 12-month, multi-centered, quasi-experimental design to assess point-of-care (POCT) screening/monitoring of subjects on antipsychotic agents for metabolic syndrome. Subjects were also randomized to either an Extended Treatment Group (ETG) defined by receiving comprehensive medication management (CMM) pharmacist interventions or a Usual Treatment Group (UTG) receiving no CMM interventions. All subjects were recruited from three community mental health clinic settings in Minnesota.

Conditions

Interventions

DEVICE

Glucose and lipids

Point-of-care (POCT) screening for diabetes and dyslipidemia. Glucose and Lipids

DEVICE

Glycosylated Hemoglobin A1c

Point-of-care (POCT) screening for diabetes Glycosylated Hemoglobin A1c

DEVICE

Blood Pressure and Heart Rate

Point-of-care (POCT) screening for hypertension Blood Pressure and Heart Rate

DEVICE

Body mass index

Height and weight measurement used to calculate BMI = Mass(kg)/(height (m))squared

DEVICE

Waist and Hip circumference

Measurement for Central Obesity Waist and Hip circumference

BEHAVIORAL

Comprehensive Medication Management

Defined at http://www.pcpcc.org/guide/patient-health-through-medication-management

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029989 on ClinicalTrials.gov